Esther A. Peterson

591 total citations
25 papers, 449 citations indexed

About

Esther A. Peterson is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Esther A. Peterson has authored 25 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Molecular Biology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Esther A. Peterson's work include Bone health and treatments (6 papers), HER2/EGFR in Cancer Research (6 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Esther A. Peterson is often cited by papers focused on Bone health and treatments (6 papers), HER2/EGFR in Cancer Research (6 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Esther A. Peterson collaborates with scholars based in United States, Puerto Rico and Netherlands. Esther A. Peterson's co-authors include Elizabeth M. Petty, Paraic A. Kenny, Maria E. González, Lisa M. Privette Vinnedge, Linda M. Kalikin, Olga V. Makarova, Kristopher A. Lofgren, Nico van Rooijen, Brian T. Beaty and Minna Roh‐Johnson and has published in prestigious journals such as Cancer Research, Oncogene and The FASEB Journal.

In The Last Decade

Esther A. Peterson

22 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esther A. Peterson United States 12 241 141 84 77 51 25 449
Yang Hong China 14 220 0.9× 127 0.9× 20 0.2× 136 1.8× 31 0.6× 40 527
Ryou Takahashi Japan 6 300 1.2× 229 1.6× 45 0.5× 128 1.7× 54 1.1× 10 525
Gulshan Sunavala‐Dossabhoy United States 14 288 1.2× 65 0.5× 98 1.2× 37 0.5× 39 0.8× 30 474
Linjing Li China 17 493 2.0× 68 0.5× 86 1.0× 118 1.5× 130 2.5× 36 636
Qinhui Song United States 8 225 0.9× 99 0.7× 44 0.5× 65 0.8× 14 0.3× 8 370
Caroline Hilmi France 8 296 1.2× 99 0.7× 69 0.8× 53 0.7× 53 1.0× 8 407
Valentina Adami Italy 13 257 1.1× 47 0.3× 35 0.4× 58 0.8× 41 0.8× 33 437
Jessica B. Casaletto United States 6 311 1.3× 118 0.8× 144 1.7× 45 0.6× 37 0.7× 7 498
R. D. Patel India 10 222 0.9× 269 1.9× 52 0.6× 104 1.4× 10 0.2× 33 611
Irene H.L. Hamelers Netherlands 11 288 1.2× 139 1.0× 75 0.9× 53 0.7× 87 1.7× 12 516

Countries citing papers authored by Esther A. Peterson

Since Specialization
Citations

This map shows the geographic impact of Esther A. Peterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther A. Peterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther A. Peterson more than expected).

Fields of papers citing papers by Esther A. Peterson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther A. Peterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther A. Peterson. The network helps show where Esther A. Peterson may publish in the future.

Co-authorship network of co-authors of Esther A. Peterson

This figure shows the co-authorship network connecting the top 25 collaborators of Esther A. Peterson. A scholar is included among the top collaborators of Esther A. Peterson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther A. Peterson. Esther A. Peterson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Peterson, Esther A., et al.. (2025). Protocol for evaluating the impact of non-coding variants on transcription factor binding and gene expression. STAR Protocols. 6(2). 103874–103874.
3.
Peterson, Esther A., et al.. (2025). Cardiovascular disease-associated non-coding variants disrupt GATA4-DNA binding and regulatory functions. Human Genetics and Genomics Advances. 6(2). 100415–100415. 1 indexed citations
4.
5.
Peterson, Esther A., et al.. (2023). High-Affinity Extended Bisphosphonate-Based Coordination Polymers as Promising Candidates for Bone-Targeted Drug Delivery. ACS Applied Materials & Interfaces. 15(28). 33397–33412. 11 indexed citations
6.
Peterson, Esther A., et al.. (2022). High affinity zoledronate-based metal complex nanocrystals to potentially treat osteolytic metastases. Materials Advances. 3(7). 3251–3266. 7 indexed citations
7.
Peterson, Esther A., et al.. (2022). Abstract 329: Understanding the role of GPR30 in the estrogen non-genomic signaling in inflammatory breast cancer. Cancer Research. 82(12_Supplement). 329–329.
8.
Peterson, Esther A., et al.. (2020). Potentiating bisphosphonate-based coordination complexes to treat osteolytic metastases. Journal of Materials Chemistry B. 8(10). 2155–2168. 21 indexed citations
9.
Peterson, Esther A., Zsuzsanna Polgár, Yanfeng Li, et al.. (2018). Genes and Pathways Promoting Long‐Term Liver Repopulation by Ex Vivo hYAP‐ERT2 Transduced Hepatocytes and Treatment of Jaundice in Gunn Rats. Hepatology Communications. 3(1). 129–146. 4 indexed citations
10.
Lofgren, Kristopher A., et al.. (2018). Mutant GATA3 Actively Promotes the Growth of Normal and Malignant Mammary Cells. Anticancer Research. 38(8). 4435–4441. 24 indexed citations
11.
Peterson, Esther A., Edmund C. Jenkins, Kristopher A. Lofgren, et al.. (2015). Amphiregulin Is a Critical Downstream Effector of Estrogen Signaling in ERα-Positive Breast Cancer. Cancer Research. 75(22). 4830–4838. 41 indexed citations
12.
Sharma, Ved P., Brian T. Beaty, Minna Roh‐Johnson, et al.. (2013). Autocrine HBEGF expression promotes breast cancer intravasation, metastasis and macrophage-independent invasion in vivo. Oncogene. 33(29). 3784–3793. 84 indexed citations
13.
Peterson, Esther A., Eirini Pectasides, Shabana Shabbeer, et al.. (2013). Evaluation of serum Amphiregulin levels in breast cancer patients and cancer-free controls. Experimental Hematology and Oncology. 2(1). 25–25. 6 indexed citations
14.
Peterson, Esther A., Shabana Shabbeer, & Paraic A. Kenny. (2012). Normal range of serum Amphiregulin in healthy adult human females. Clinical Biochemistry. 45(6). 460–463. 13 indexed citations
15.
Peterson, Esther A., et al.. (2011). SEPT9_i1 and genomic instability: Mechanistic insights and relevance to tumorigenesis. Genes Chromosomes and Cancer. 50(11). 940–949. 12 indexed citations
16.
Landsverk, Megan, Elizabeth K. Ruzzo, Heather C. Mefford, et al.. (2009). Duplication within the SEPT9 gene associated with a founder effect in North American families with hereditary neuralgic amyotrophy. Human Molecular Genetics. 18(7). 1200–1208. 22 indexed citations
17.
González, Maria E., Olga V. Makarova, Esther A. Peterson, Lisa M. Privette Vinnedge, & Elizabeth M. Petty. (2008). Up-regulation of SEPT9_v1 stabilizes c-Jun-N-Terminal kinase and contributes to its pro-proliferative activity in mammary epithelial cells. Cellular Signalling. 21(4). 477–487. 43 indexed citations
18.
González, Maria E., et al.. (2007). High SEPT9_v1 Expression in Human Breast Cancer Cells Is Associated with Oncogenic Phenotypes. Cancer Research. 67(18). 8554–8564. 67 indexed citations
19.
Peterson, Esther A., et al.. (2007). Characterization of a SEPT9 interacting protein, SEPT14, a novel testis-specific septin. Mammalian Genome. 18(11). 796–807. 41 indexed citations
20.
McCubbrey, D. A., Dianna D. Cody, Gary J. Gross, et al.. (1992). Relationships between regional material properties, density, and architecture of the human proximal femur. 131–133. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yang Hong Breakdown of academic impact, for papers by Ryou Takahashi Breakdown of academic impact, for papers by Gulshan Sunavala‐Dossabhoy Breakdown of academic impact, for papers by Linjing Li Breakdown of academic impact, for papers by Qinhui Song Breakdown of academic impact, for papers by Caroline Hilmi Breakdown of academic impact, for papers by Valentina Adami Breakdown of academic impact, for papers by Jessica B. Casaletto Breakdown of academic impact, for papers by R. D. Patel Breakdown of academic impact, for papers by Irene H.L. Hamelers
Rankless by CCL
2026